# Jens von Bahr > Jens von Bahr is a funding round investor at Dopamine backing Health Care and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026. - Type: Angel Investor - Fund: [Dopamine](https://shizune.co/investors/profile/dopamine-2) - Total investments: 4 - Last investment: Mar 2024 - Lead investor: 0% - Last updated: Aug 2026 - LinkedIn: https://www.linkedin.com/in/jens-von-bahr-6ab3075/ Jens von Bahr is a funding round investor at Dopamine focused on Health Care and Biotechnology. Jens von Bahr is the CEO and Co-Founder at Evolution Gaming. Jens von Bahr attended Stockholm University. ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Health Care | 2 | 50% | | Biotechnology | 2 | 50% | | Art | 1 | 25% | | Medical | 1 | 25% | | Auctions | 1 | 25% | 10 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Funding Round | 2 | 50% | | Seed | 1 | 25% | | Series A | 1 | 25% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Cellcolabs | Cellcolabs is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications. | $8.7M | Venture - Series Unknown | Mar 05, 2024 | | | Single Technologies | SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq. | $5.3M | Series A | Dec 03, 2020 | | | Barnebys | Barnebys is the world’s leading search service for art, antiques and collectibles. We were founded in Stockholm, Sweden in 2011 and have since then established our business globally with offices in New York, UK, France, Spain and Germany. Our clients include the world’s top tier of auctioneers, antique dealers, galleries as well as regional andlocal businesses. We are also offering an extensive free database of auction results and a top of the line valuation service. We are now looking to grow our business even further and are seeking top talent to join our team. | | | Nov 15, 2017 | | | Single Technologies | SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq. | $7.7M | Seed | | | 4 of 4 investments shown. ## Co-investors - [Accum Kapital](https://shizune.co/investors/profile/accum-kapital) — VC Fund, 1 deal together - [Inbox](https://shizune.co/investors/profile/inbox) — VC Fund, 1 deal together - [Industrifonden](https://shizune.co/investors/profile/industrifonden) — VC Fund, 1 deal together - [Kichi Invest](https://shizune.co/investors/profile/kichi-invest) — VC Fund, 1 deal together - [Norrsken VC](https://shizune.co/investors/profile/norrsken-vc) — VC Fund, 1 deal together ## About Dopamine VC Fund 1 contacts available at Dopamine. | Name | Title | Profile | | --- | --- | --- | | Jens von Bahr | CEO and Co-Founder | https://shizune.co/investors/profile/jens-von-bahr | ## Similar investors ### Similar industry - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund - [Galaxy Interactive](https://shizune.co/investors/profile/galaxy-interactive) — VC Fund - [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund ### Similar stage - [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund - [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund - [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund ### Similar country - [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund - [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund - [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund ## Featured in investor lists - [Biotech Angel Investors in Sweden](https://shizune.co/investors/biotech-angel-investors-sweden) - [Biotechnology Investors in Sweden](https://shizune.co/investors/biotechnology-investors-sweden) - [Biotech Investors in Sweden](https://shizune.co/investors/biotech-investors-sweden) - [Medical Device Investors in Sweden](https://shizune.co/investors/medical-device-investors-sweden) - [Medical Device Angel Investors in Sweden](https://shizune.co/investors/medical-device-angel-investors-sweden) - [Machine Learning Investors in Sweden](https://shizune.co/investors/machine-learning-investors-sweden) ## FAQ ### What does Jens von Bahr invest in? Jens von Bahr invests primarily in Health Care, Biotechnology and Art startups, most often at Funding Round and Seed stage. Most of the 4 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### When did Jens von Bahr last invest? The most recent investment recorded for Jens von Bahr closed in Mar 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co